Targeting The Il-12/23 Pathway In Ibd: Q&A

Targeting the IL-12/23 Pathway in IBD

Targeting the IL-12/23 Pathway in IBD: Q&A

New Biologic Therapies that Target the IL-12/23 Pathway

Advances in Anti-Cytokine Therapy for IBD: The Role of IL-12/23 and IL-23 Inhibitors

Positioning anti-IL-12 and anti-IL-23 inhibitors

Exploring Immune Cell Trafficking Inhibitors to Treat IBD

The Evolving Therapeutic Paradigm in IBD: Optimal Positioning of New and Emerging Agents

Treat to Target in IBD

Treat-to-Target in IBD: Decreasing Inflammation & Achieving Mucosal Healing

PCH Grand Rounds - Precision Medicine for IBD - Dr. Marla Dubinsky

Phoenix Children's Medical Education

Mechanisms of Disease: Unraveling the Small Molecule Pipeline for IBD

IBD: Safety and Positioning of IL-23 Inhibitors Under Investigation

Genetics after Genome-wide Association Studies: Inflammatory Bowel Disease

Advances in Anti-Cytokine Therapy: New Pathways (IL 12/23, IL17, IL23)

ClevelandClinicCME

IBD Clinical Update: New and Emerging Targeted Therapies

Positioning IBD Therapies

Positioning of Biologics and New Therapeutics for Crohn's Disease

Advances in Anti Cytokine Therapy: Mechanisms of Action and Efficacy

Understanding non-response and loss of response in IBD: Which is it and when do we change classes?

Targeting IBD: Hitting the Mark in Today’s Treatment Landscape